Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, People's Republic of China.
World J Surg Oncol. 2018 Jul 5;16(1):130. doi: 10.1186/s12957-018-1436-0.
Thyroid and breast cancer are two of the malignant diseases with highest incidence in females. Based on clinical experience, breast and thyroid cancer often occur metachronously or synchronously. Therefore, thyroid and breast cancer might share some common etiological factors. The relationship between these diseases has attracted substantial attention, and because these two glands are both regulated by the hypothalamic-pituitary axis, such a relationship is not surprising. A study of this relationship will be useful for obtaining a better understanding of the mechanism by which these two malignancies co-occur.
This study reviewed the progress in research on the roles of iodine intake, folate metabolism, obesity, gonadal hormones, and thyroid hormone in thyroid and breast cancer. These studies evaluating the etiological roles of these factors in linking breast and thyroid cancer might also improve our understanding and identify new therapeutic approaches, such as sodium/iodide symporter-mediated radioiodine therapy and thyroid-stimulating hormone receptor antagonists, for breast cancer. In addition, some specific treatments for each cancer, such as radiotherapy for breast cancer or radioactive iodine therapy for thyroid cancer, might be risk factors for secondary malignances, including breast and thyroid cancer.
Studies of the precise relationship between the co-occurrence of breast and thyroid cancer will certainly improve our understanding of the biological behaviors of these two malignancies and direct evidence-based clinical practice.
甲状腺癌和乳腺癌是女性中发病率最高的两种恶性肿瘤。根据临床经验,乳腺癌和甲状腺癌常同时或先后发生。因此,甲状腺癌和乳腺癌可能具有一些共同的病因。这些疾病之间的关系引起了广泛关注,由于这两个腺体都受下丘脑-垂体轴的调节,因此这种关系并不奇怪。研究这种关系有助于更好地了解这两种恶性肿瘤同时发生的机制。
本研究回顾了碘摄入、叶酸代谢、肥胖、性腺激素和甲状腺激素在甲状腺癌和乳腺癌中的作用的研究进展。这些评估这些因素在乳腺癌和甲状腺癌之间的病因学作用的研究,也可能改善我们的认识,并确定新的治疗方法,如钠/碘转运体介导的放射性碘治疗和促甲状腺激素受体拮抗剂,用于治疗乳腺癌。此外,某些特定的癌症治疗方法,如乳腺癌的放疗或甲状腺癌的放射性碘治疗,可能是继发性恶性肿瘤的危险因素,包括乳腺癌和甲状腺癌。
对乳腺癌和甲状腺癌同时发生的确切关系的研究,必将提高我们对这两种恶性肿瘤生物学行为的认识,并为循证临床实践提供指导。